SOLUBLE HUMAN MACROPHAGE FACTORS ARE ABLE TO INHIBIT TGF-Β-INDUCED DIFFERENTIATION OF LUNG FIBROBLASTS



Cite item

Full Text

Abstract

AbstractMacrophages are key regulatory cells of fibrogenesis. They can have pro- or antifibrotic activity due to their plasticity and heterogeneity. Some studies have shown the antifibrotic effect of macrophages on dermal fibroblasts, but the effect of macrophages on the lung fibroblast functions remains unexplored. Therefore, the purpose of this study was to examine the influence of conditioned media of human macrophage differentiated by M-CSF/GM-CSF and further dexamethasone polarized/unpolarized on the TGF-β-induced lung fibroblast differentiation. Macrophages were derived from peripheral blood monocytes of healthy donors. Monocytes were differentiated by M-CSF or GM-CSF for 7 days. On day 5, dexamethasone was added to generation of polarized macrophages M-M(Dex) and GM-M(Dex). Polarized macrophages were compared with non-polarized M-M0 and GM-M0, to which dexamethasone was not added. Next, the conditioned medium of these macrophage subtypes was collected and tested for inhibition the lung fibroblast differentiation (HLF210 cell line). To do this, TGF-β (inducing differentiation factor) and conditioned macrophage medium were added to fibroblast cultures. Effectiveness of differentiation was estimated by the expression of the myofibroblast marker, α-smooth muscle actin (α-SMA), and the production of extracellular matrix protein, collagen I. The expression of α-SMA was determined using flow cytometry. The concentration of collagen I was measured by ELISA. Since our data indicates that spontaneous activation of fibroblasts occurs during standard cultivation, the α-SMA expression was investigated in 3D culture of fibroblasts. Notably, the content of α-SMA-positive cells in 3D cultures was significantly reduced, indicating more physiological growth cells. Regardless of the differentiation stimulus, the conditioned media of dexamethasone-polarized macrophages do not affect the level of collagen I production or the α-SMA expression. On the contrary, M-M0 showed a strong inhibitory effect that reduced the amount of collagen I in the fibroblast cultures and the expression of marker myofibroblasts by fibroblasts. Interesting, GM-M0 had no such effect and did not prevent lung fibroblast differentiation like polarized cells. Taken together, the findings suggest that M-M0 macrophages may have antifibrotic properties. Furthermore, the lack of this effect in GM-M0 macrophages indicates that the differentiation factor plays a significant role in the development of the antifibrotic macrophage phenotype.

About the authors

Aleksandra A. Maksimova

Laboratory of Cellular Immunotherapy, Federal State Budgetary Scientific Institution Research Institute of Fundamental and Clinical Immunology

Email: parkinson.dses@gmail.com
ORCID iD: 0000-0003-0884-0226
SPIN-code: 4440-8387
Scopus Author ID: 58001110800
ResearcherId: AAD-1576-2019

Candidate of Science in Medicine, Junior Researcher of Laboratory of cellular immunotherapy

Russian Federation

Ekaterina Ya. Shevela

Laboratory of Cellular Immunotherapy, Federal State Budgetary Scientific Institution Research Institute of Fundamental and Clinical Immunology

Email: shevelak@mail.ru
ORCID iD: 0000-0001-8997-3586
SPIN-code: 6883-5594

Doctor of Sciences in Medicine, Leading Researcher of Laboratory of Cellular Immunotherapy

Russian Federation, Novosibirsk, Yadrintsevskaya, 14

Ludmila V. Sakno

Laboratory of Cellular Immunotherapy, Federal State Budgetary Scientific Institution Research Institute of Fundamental and Clinical Immunology

Author for correspondence.
Email: lsahno53@mail.ru
ORCID iD: 0000-0003-3290-7910
SPIN-code: 1109-4196

Candidate of Science in Biology, Senior Researcher of Laboratory of cellular immunotherapy

Russian Federation

References

  1. Bagalad B.S., Mohan Kumar K.P., Puneeth H.K. Myofibroblasts: Master of disguise. Journal of Oral Maxillofacial Pathology. 2017, Vol. 21, no.3, pp. 462-463
  2. Brennan P.N., MacMillan M., Manship T., Moroni F., Glover A., Graham C., Semple S., Morris D.M., Fraser A.R., Pass C., McGowan N.W.A., Turner M.L., Lachlan N., Dillon J.F., Campbell J.D.M., Fallowfield J.A., Forbes S.J. Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ Open, 2021, Vol. 11, no.11, pp. e053190
  3. Chang C.H., Juan Y.H., Hu H.C., Kao K.C., Lee C.S. Reversal of lung fibrosis: an unexpected finding in survivor of acute respiratory distress syndrome. QJM, 2018, Vol. 111, no.1, pp. 47-48
  4. Koudelka A., Cechova V., Rojas M., Mitash N., Bondonese A., St Croix C., Ross M.A., Freeman B.A. Fatty acid nitroalkene reversal of established lung fibrosis. Redox Biology, 2022, Vol. 50, pp. 102226
  5. Landry N.M., Rattan S.G., Dixon, I.M.C. An Improved Method of Maintaining Primary Murine Cardiac Fibroblasts in Two-Dimensional Cell Culture. Scientific Reports, 2019, no.9, pp. 12889
  6. Machahua C, Vicens-Zygmunt V, Ríos-Martín J, Llatjós R, Escobar-Campuzano I, Molina-Molina M, Montes-Worboys A. Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis. Experimental Lung Research, 2022, Vol. 48, no.3, pp. 126-136
  7. Meng X.M., Nikolic-Paterson D.J., Lan H.Y. TGF-β: the master regulator of fibrosis. Nature Reviews Nephrology. 2016, Vol. 12, no.6, pp. 325-338
  8. Mikkelsen L.F., Rubak S. Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment. BMC Pulmonary Medicine, 2020, Vol. 20, pp. 313
  9. Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., Gordon S., Hamilton J.A., Ivashkiv L.B., Lawrence T., Locati M., Mantovani A., Martinez F.O., Mege J.L., Mosser D.M., Natoli G., Saeij J.P., Schultze J.L., Shirey K.A., Sica A., Suttles J., Udalova I., van Ginderachter J.A., Vogel S.N., Wynn T.A. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014, Vol. 41, no.1, pp. 14-20
  10. Sapudom J., Karaman S., Mohamed W.K.E., Garcia-Sabaté A., Quartey B.C., Teo J.C.M. 3D in vitro M2 macrophage model to mimic modulation of tissue repair. npj Regenerative Medicine, 2021, no.6, p. 83
  11. Sari E., He C., Margaroli C. Plasticity towards Rigidity: A Macrophage Conundrum in Pulmonary Fibrosis. International Journal of Molecular Sciences. 2022, Vol. 23, no.19, pp. 11443
  12. Song E., Ouyang N., Hörbelt M., Antus B., Wang M., Exton M.S. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cellular Immunology, 2000, Vol. 204, no.1, pp. 19-28
  13. Tarique A.A., Logan J., Thomas E., Holt P.G., Sly P.D., Fantino E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. American Journal of Respiratory Cell and Molecular Biology, 2015, Vol. 53, no.5, pp. 676-688
  14. Ullm F., Riedl P., Machado de Amorim A., Patzschke A., Weiß R., Hauschildt S., Franke K., Anderegg U., Pompe T. 3D Scaffold-Based Macrophage Fibroblast Coculture Model Reveals IL-10 Dependence of Wound Resolution Phase. Advanced Biosystems, 2020, Vol. 4, no.1, pp. e1900220
  15. Xue J., Schmidt S.V., Sander J., Draffehn A., Krebs W., Quester I., De Nardo D., Gohel T.D., Emde M., Schmidleithner L., Ganesan H., Nino-Castro A., Mallmann M.R., Labzin L., Theis H., Kraut M., Beyer M., Latz E., Freeman T.C., Ulas T., Schultze J.L. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014, Vol. 40, no.2, pp. 274-88

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Maksimova A.A., Shevela E.Y., Sakno L.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies